HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines.

Abstract
Cepharanthine (CEP) is a known membrane stabilizer that has been widely used in Japan for the treatment of several disorders such as anticancer therapy-provoked leukopenia. We here report that apoptosis was induced by low concentrations (1-5 microM) of CEP in a human leukemia T cell line, Jurkat, and by slightly higher concentrations (5-10 microM) in a human chronic myelogenous leukemia (CML) cell line K562, which expresses a p210 antiapoptotic Bcr-Abl fusion protein. Induction of apoptosis was confirmed in both Jurkat and K562 cells by DNA fragmentation and typical apoptotic nuclear change, which were preceded by disruption of mitochondrial membrane potential and were induced through a Fas-independent pathway. CEP treatment induced activation of caspase-9 and -3 accompanied by cleavage of PARP, Bid, lamin B1, and DFF45/ICAD in both Jurkat and K562 cells, whereas caspase-8 activation and Akt cleavage were observed only in Jurkat cells. The CEP-induced apoptosis was completely blocked by zVAD-fmk, a broad caspase inhibitor. Interestingly, CEP treatment induced remarkable degradation of the Bcr-Abl protein in K562 cells, and this degradation was prevented partially by zVAD-fmk. When used in combination with a nontoxic concentration of herbimycin A, lower concentrations (2-5 microM) of CEP induced obvious apoptosis in K562 cells with rapid degradation or decrease in the amount of Bcr-Abl and Akt proteins. Our results suggest that CEP, which does not have bone marrow toxicity, may possess therapeutic potential against human leukemias, including CML, which is resistant to anticancer drugs and radiotherapy.
AuthorsJ Wu, H Suzuki, Y W Zhou, W Liu, M Yoshihara, M Kato, A A Akhand, A Hayakawa, K Takeuchi, K Hossain, M Kurosawa, I Nakashima
JournalJournal of cellular biochemistry (J Cell Biochem) Vol. 82 Issue 2 Pg. 200-14 ( 2001) ISSN: 0730-2312 [Print] United States
PMID11527146 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Alkaloids
  • Amino Acid Chloromethyl Ketones
  • Antineoplastic Agents, Phytogenic
  • Apoptosis Regulatory Proteins
  • BH3 Interacting Domain Death Agonist Protein
  • BID protein, human
  • Benzoquinones
  • Benzylisoquinolines
  • Carrier Proteins
  • Cysteine Proteinase Inhibitors
  • Enzyme Inhibitors
  • FASLG protein, human
  • Fas Ligand Protein
  • Lactams, Macrocyclic
  • Lamin Type B
  • Lamins
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proteins
  • Proto-Oncogene Proteins
  • Quinones
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • caspase-activated DNase inhibitor
  • fas Receptor
  • lamin B1
  • Rifabutin
  • herbimycin
  • cepharanthine
  • Poly(ADP-ribose) Polymerases
  • Fusion Proteins, bcr-abl
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Caspases
Topics
  • Alkaloids (pharmacology)
  • Amino Acid Chloromethyl Ketones (pharmacology)
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (drug effects)
  • Apoptosis Regulatory Proteins
  • BH3 Interacting Domain Death Agonist Protein
  • Benzoquinones
  • Benzylisoquinolines
  • Carrier Proteins (metabolism)
  • Caspases (metabolism)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • DNA Fragmentation
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Enzyme Activation (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Fas Ligand Protein
  • Fusion Proteins, bcr-abl (antagonists & inhibitors, metabolism)
  • Humans
  • Intracellular Membranes (drug effects, ultrastructure)
  • Jurkat Cells (cytology, drug effects, enzymology)
  • K562 Cells (cytology, drug effects, enzymology)
  • Lactams, Macrocyclic
  • Lamin Type B
  • Lamins
  • Membrane Glycoproteins (physiology)
  • Mitochondria (drug effects, ultrastructure)
  • Neoplasm Proteins (metabolism)
  • Nuclear Proteins (metabolism)
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Protein Serine-Threonine Kinases
  • Proteins (metabolism)
  • Proto-Oncogene Proteins (antagonists & inhibitors, metabolism)
  • Proto-Oncogene Proteins c-akt
  • Quinones (pharmacology)
  • Rifabutin (analogs & derivatives)
  • fas Receptor (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: